Cargando…

Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors

Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life‐sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision‐making process on withdraw life‐sustaining treatment and whether time...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsopoulos, Angela M., Jansen, Nichon E., Vos, Piet, Witjes, Marloes, Volbeda, Meint, Epker, Jelle L., Sonneveld, Hans P. C., Simons, Koen S., Bronkhorst, Ewald M., van der Hoeven, Hans G., Abdo, Wilson F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754148/
https://www.ncbi.nlm.nih.gov/pubmed/32506559
http://dx.doi.org/10.1111/ajt.16104
_version_ 1783626136168693760
author Kotsopoulos, Angela M.
Jansen, Nichon E.
Vos, Piet
Witjes, Marloes
Volbeda, Meint
Epker, Jelle L.
Sonneveld, Hans P. C.
Simons, Koen S.
Bronkhorst, Ewald M.
van der Hoeven, Hans G.
Abdo, Wilson F.
author_facet Kotsopoulos, Angela M.
Jansen, Nichon E.
Vos, Piet
Witjes, Marloes
Volbeda, Meint
Epker, Jelle L.
Sonneveld, Hans P. C.
Simons, Koen S.
Bronkhorst, Ewald M.
van der Hoeven, Hans G.
Abdo, Wilson F.
author_sort Kotsopoulos, Angela M.
collection PubMed
description Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life‐sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision‐making process on withdraw life‐sustaining treatment and whether time from admission to family approach, influences family consent rates. Such insights could be important in improving the clinical practice of potential cDCD donors. In a prospective multicenter observational study, we evaluated the impact of timing and of the clinical factors during the end‐of‐life decision‐making process in potential cDCD donors. Characteristics and medication use of 409 potential cDCD donors admitted to the intensive care units (ICUs) were assessed. End‐of‐life decision‐making was made after a mean time of 97 hours after ICU admission and mostly during the day. Intracranial hemorrhage or ischemic stroke and a high APACHE IV score were associated with a short decision‐making process. Preserved brainstem reflexes, high Glasgow Coma Scale scores, or cerebral infections were associated with longer time to decision‐making. Our data also suggest that the organ donation request could be made shortly after the decision to stop active treatment and consent rates were not influenced by daytime or nighttime or by the duration of the ICU stay.
format Online
Article
Text
id pubmed-7754148
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77541482020-12-23 Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors Kotsopoulos, Angela M. Jansen, Nichon E. Vos, Piet Witjes, Marloes Volbeda, Meint Epker, Jelle L. Sonneveld, Hans P. C. Simons, Koen S. Bronkhorst, Ewald M. van der Hoeven, Hans G. Abdo, Wilson F. Am J Transplant Brief Communications Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life‐sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision‐making process on withdraw life‐sustaining treatment and whether time from admission to family approach, influences family consent rates. Such insights could be important in improving the clinical practice of potential cDCD donors. In a prospective multicenter observational study, we evaluated the impact of timing and of the clinical factors during the end‐of‐life decision‐making process in potential cDCD donors. Characteristics and medication use of 409 potential cDCD donors admitted to the intensive care units (ICUs) were assessed. End‐of‐life decision‐making was made after a mean time of 97 hours after ICU admission and mostly during the day. Intracranial hemorrhage or ischemic stroke and a high APACHE IV score were associated with a short decision‐making process. Preserved brainstem reflexes, high Glasgow Coma Scale scores, or cerebral infections were associated with longer time to decision‐making. Our data also suggest that the organ donation request could be made shortly after the decision to stop active treatment and consent rates were not influenced by daytime or nighttime or by the duration of the ICU stay. John Wiley and Sons Inc. 2020-08-26 2020-12 /pmc/articles/PMC7754148/ /pubmed/32506559 http://dx.doi.org/10.1111/ajt.16104 Text en © 2020 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communications
Kotsopoulos, Angela M.
Jansen, Nichon E.
Vos, Piet
Witjes, Marloes
Volbeda, Meint
Epker, Jelle L.
Sonneveld, Hans P. C.
Simons, Koen S.
Bronkhorst, Ewald M.
van der Hoeven, Hans G.
Abdo, Wilson F.
Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
title Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
title_full Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
title_fullStr Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
title_full_unstemmed Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
title_short Determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
title_sort determining the impact of timing and of clinical factors during end‐of‐life decision‐making in potential controlled donation after circulatory death donors
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754148/
https://www.ncbi.nlm.nih.gov/pubmed/32506559
http://dx.doi.org/10.1111/ajt.16104
work_keys_str_mv AT kotsopoulosangelam determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT jansennichone determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT vospiet determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT witjesmarloes determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT volbedameint determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT epkerjellel determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT sonneveldhanspc determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT simonskoens determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT bronkhorstewaldm determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT vanderhoevenhansg determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors
AT abdowilsonf determiningtheimpactoftimingandofclinicalfactorsduringendoflifedecisionmakinginpotentialcontrolleddonationaftercirculatorydeathdonors